$KYTX 8-K SEC Filings

Filed On	Filing
24 Sep 2026	8-K: Regulation FD Disclosure Kyverna Therapeutics Reports Positive One-Year Data Demonstrating Durable Clinical Responses and Favorable Safety Profile for Miv-cel in Stiff Person Syndrome and Generalized Myasthenia Gravis
11 Aug 2026	8-K: Results of Operations and Financial Condition
27 Jul 2026	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
09 Jul 2026	8-K: Entry into a Material Definitive Agreement
02 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
18 May 2026	8-K: Departure/Election of Directors or Officers; Compensation; Other Events
12 May 2026	8-K: Results of Operations and Financial Condition
04 May 2026	8-K: Other Events
22 Apr 2026	8-K: Regulation FD Disclosure
22 Apr 2026	8-K: Regulation FD Disclosure
20 Apr 2026	8-K: Regulation FD Disclosure
26 Mar 2026	8-K: Results of Operations and Financial Condition
24 Feb 2026	8-K: Departure/Election of Directors or Officers; Compensation; Other Events
03 Feb 2026	8-K: Departure/Election of Directors or Officers; Compensation; Other Events
12 Jan 2026	8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation
18 Dec 2025	8-K: Entry into a Material Definitive Agreement; Other Events
15 Dec 2025	8-K: Regulation FD Disclosure
15 Dec 2025	8-K: Regulation FD Disclosure
12 Nov 2025	8-K: Results of Operations and Financial Condition
03 Nov 2025	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more

Comments